ACURA PHARMACEUTICALS, INC·4

Dec 12, 4:12 PM ET

ACURA PHARMACEUTICALS, INC 4

4 · ACURA PHARMACEUTICALS, INC · Filed Dec 12, 2016

Insider Transaction Report

Form 4
Period: 2016-12-08
Jones Robert B
Sr. VP & COO
Transactions
  • Award

    Stock Options

    2016-12-08+47,00047,000 total
    Exercise: $0.92Exp: 2026-12-07Common Stock (47,000 underlying)
Footnotes (3)
  • [F1]Exercise price is closing price of Issuer's common stock on December 8, 2016.
  • [F2]one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2016 and ending on November 30, 2018. Option vesting and exercisability is accelerated upon a qualifying change of control and on termination of employment for certain reasons.
  • [F3]Not Applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION